Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176753 | SCV000228462 | uncertain significance | not provided | 2015-04-21 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847814 | SCV002104809 | uncertain significance | Hereditary spastic paraplegia | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852179 | SCV002295153 | uncertain significance | Hereditary spastic paraplegia 8; Ritscher-Schinzel syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1099 of the KIAA0196 protein (p.Ile1099Thr). This variant is present in population databases (rs373599521, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with KIAA0196-related conditions. ClinVar contains an entry for this variant (Variation ID: 196031). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KIAA0196 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV000176753 | SCV004224213 | uncertain significance | not provided | 2023-02-21 | criteria provided, single submitter | clinical testing | BS2, PP3 |